Advances of Smart Stimulus‐Responsive Microneedles in Cancer Treatment
Small Methods · 2024-09 · 8 (9)
DOI: 10.1002/smtd.202301455 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 26.12.2023. Verfasst von Huaqing Chu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science…. Hauptthemen laut MEDLINE: Neoplasms, Needles, Drug Delivery Systems, Antineoplastic Agents. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 215 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Microneedles (MNs) have emerged as a highly promising technology for delivering drugs via the skin. They provide several benefits, including high drug bioavailability, non‐invasiveness, painlessness, and high safety. Traditional strategies for intravenous delivery of anti‐tumor drugs have risks of systemic toxicity and easy development of drug resistance, while MN technology facilitates precise delivery and on‐demand release of drugs in local tissues. In addition, by further combining with stimulus‐responsive materials, the construction of smart stimulus‐responsive MNs can be achieved, which can respond to specific physical/chemical stimuli from the internal or external environment, thereby further improving the accuracy of tumor treatment and reducing toxicity to surrounding tissues/cells. This review systematically summarizes the classification, materials, and reaction mechanisms of stimulus‐responsive MNs, outlines the benefits and challenges of various types of MNs, and details their application and latest progress in cancer treatment. Finally, the development prospects of smart MNs in tumor treatment are also discussed, bringing inspiration for future precision treatment of tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
- Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, 101400, China.
- School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China.
- Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
ORCID-Profile: Zhou Li
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Chu, H., Xue, J., Yang, Y., Zheng, H., Luo, D., & Li, Z. (2024). Advances of Smart Stimulus‐Responsive Microneedles in Cancer Treatment. Small Methods, 8(9). https://doi.org/10.1002/smtd.202301455
Vancouver
Chu H, Xue J, Yang Y, Zheng H, Luo D, Li Z. Advances of Smart Stimulus‐Responsive Microneedles in Cancer Treatment. Small Methods. 2024;8(9). doi:10.1002/smtd.202301455
BibTeX
@article{Chu2024,
author = {Chu, Huaqing and Xue, Jiangtao and Yang, Yuan and Zheng, Hui and Luo, Dan and Li, Zhou},
title = {Advances of Smart Stimulus‐Responsive Microneedles in Cancer Treatment},
journal = {Small Methods},
year = {2024},
volume = {8},
number = {9},
doi = {10.1002/smtd.202301455}
}
EUVIMED